Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 7:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 2,293 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiac Ischemia Clear all

Conditions: Ischemia
Interventions: BMS747158; Drug
Lead sponsor: Lantheus Medical Imaging; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 24
States / cities: Fremont, California • La Jolla, California • Los Angeles, California + 18 more

Conditions: Coronary Occlusion
Interventions: Catheter-based intracoronary injection; Biological
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chest Pain
Interventions: Aspirin, Lisinopril, Simvastatin, Lovaza, Therapeutic Lifestyle Changes; Drug · Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 90 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Peripartum Cardiomyopathy, Cardiogenic Shock
Interventions: Clinical placement of a temporary IMPELLA® mechanical circulatory support device.; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Coronary Artery Disease, Ischemia
Interventions: Computed Tomography Angiography; Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: 45 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Angina Pectoris, Coronary Artery Disease
Interventions: Paclitaxel Nanoparticle Albumin Bound; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hyperlipidemia, Coronary Artery Disease
Interventions: Pharmacist Intervention in lipid therapy; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Concord, North Carolina

Conditions: Heart Failure, Transplant; Failure, Heart
Interventions: Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Preservation System (XHPS); Device
Lead sponsor: XVIVO Perfusion; Industry
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 20
States / cities: La Jolla, California • Los Angeles, California • Palo Alto, California + 14 more

Conditions: Coronary Artery Disease
Interventions: Atorvastatin; Drug
Lead sponsor: Indiana University; Other
Eligibility: 21 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Acute Coronary Syndrome
Interventions: Point of Care testing; Device
Lead sponsor: Integrated Medical Research LLC; Other
Eligibility: 35 Years and older
Enrollment: 705 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Chest Pain, Myocardial Ischemia
Interventions: RACE-IT Pathway, Standard of Care; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 32,609 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Heart Diseases
Interventions: Survey; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Coronary Artery Stenosis, Myocardial Revascularization, Myocardial Ischemia
Interventions: Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting; Procedure
Lead sponsor: Ministry of Science and Higher Education, Poland; Government
Eligibility: 18 Years to 80 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 2
States / cities: Bryn Mawr, Pennsylvania • San Antonio, Texas

Conditions: Myocardial Infarction, Anemia
Interventions: Red Blood Cell Transfusion; Biological
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 3,506 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 60
States / cities: Little Rock, Arkansas • Los Angeles, California • Danbury, Connecticut + 48 more

Conditions: Coronary Artery Disease
Interventions: Gadobutrol (Gadavist, Gadovist, BAY86-4875); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 478 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 15
States / cities: Tucson, Arizona • Los Angeles, California • Atlanta, Georgia + 11 more

Conditions: Coronary Artery Disease (CAD), Renal Impairment, Diabetes Mellitus
Interventions: Iodixanol, Ioversol, Iopromide; Drug
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Post-menopause
Interventions: Study Procedures; Other
Lead sponsor: Emory University; Other
Eligibility: 45 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 4
States / cities: Atlanta, Georgia

Conditions: Myocardial Infarction
Interventions: Allogeneic Mesenchymal Precursor Cells (MPCs), Standard-of-care treatment with NOGA® mapping and staged injections.; Genetic · Procedure
Lead sponsor: Angioblast Systems; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Houston, Texas

Conditions: Anemia, Hematologic Diseases, Cardiovascular Diseases, Heart Diseases, Myocardial Infarction, Thromboembolism, Pneumonia, Cerebrovascular Accident
Interventions: Liberal (10 g/dL) Transfusion Strategy, Restrictive (Symptomatic) Transfusion Strategy; Biological
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 50 Years and older
Enrollment: 2,016 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Acute Coronary Syndrome
Interventions: Intervention, Usual care; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 4
States / cities: Little Rock, Arkansas • Denver, Colorado • Durham, North Carolina + 1 more

Conditions: Diabetes Mellitus, Coronary Artery Disease, Osteoporosis, Hypertension, Hyperlipidemia
Interventions: Computerized Reminders Medications Monitoring, Computerized Test Results Management Application, Computerized Reminders Hypertension Management, Computerized Reminders Osteoporosis Screening and Mgt; Behavioral
Lead sponsor: Agency for Healthcare Research and Quality (AHRQ); Federal
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: ISCHEMIC CARDIOMYOPATHY
Interventions: Manganese-enhanced MRI contrast reagent, Gadolinium-enhanced MRI contrast reagent; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Coronary Artery Bypass Graft Surgery, Myocardial Ischemia, Reperfusion Injury, Myocardial Revascularization
Interventions: (MC-1) Pyridoxal-5'-phosphate; Drug
Lead sponsor: Medicure; Industry
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Myocardial Infarction, Arthritis
Interventions: Aspirin First, Aspirin Last, Acetaminophen 1000 mg/d, Acetaminophen 4000 mg/d, Ibuprofen 800 mg/d; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 55 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158

Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions

Women With Chest Pain and Normal Coronary Arteries Study

PPCM Observational Study (Peripartum Cardiomyopathy)

Dynamic Computed Tomography Myocardial Perfusion Imaging for Detection of Coronary Artery Disease

A Safety Study of ABI-007 for In-Stent Restenosis

Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention

XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)

Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)

Improving the Management of Acute Coronary Syndromes in the Emergency Department

Rapid Acute Coronary Syndrome Exclusion Using High-sensitivity I Troponin

Cost Effectiveness and Utility of Computed Tomography Angiography (CTA) and Cardiac Cath

Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study)

Myocardial Ischemia and Transfusion

Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

Mental Stress Reactivity in Women With CMD

Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction

Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease

Patient-Centered Adherence Intervention After Acute Coronary Syndrome (ACS) Hospitalization

Improving Quality With Outpatient Decision Support

Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury

MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)

Mechanisms of Action of Acetaminophen